Microcap Ledger Pluri Inc. $PLUR
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Haifa
- Fiscal year end
- June 30
- Shares outstanding
- 12,344,736 [10-K 2026-09-10]
What the company doesAI summary of filing
Pluri Inc. is a biotechnology company developing cell-based products and therapies using its proprietary 3D cell expansion platform and GMP-compliant manufacturing facility. The company operates in two primary areas: Human Health and Longevity, where it develops cell therapy candidates (PLX-PAD and PLX-R18 for indications including muscle injuries, respiratory distress, and radiation syndrome), offers contract development and manufacturing services through PluriCDMO, and recently launched regenerative aesthetics products through its Cellav subsidiary; and Foodtech and Bio-Farming, where it is developing cultivated coffee through Coffeesai, cultivated cacao through Kokomodo, and cultivated meat through Ever After Foods. Pluri is a clinical-stage company with revenue from CDMO services and development partnerships, and is pursuing regulatory approvals for its cell therapy candidates while advancing early-stage commercialization efforts in aesthetics and food technology. [10-K 2026-09-10]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| FY ended Jun 2026 | $1.02M | −$23.82M | −$19.59M | $3.53M | [10-K 2026-09-10] |
| FY ended Jun 2025 | $1.34M | −$22.58M | −$18.21M | $5.89M | [10-K 2026-09-10] |
- Quarterly cash burn
- −$4.90M
- Cash runway Estimate
- ~2.2 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-11 | 5,558,662 | [10-Q 2024-11-12] |
| 2025-02-10 | 6,997,140 | [10-Q 2025-02-11] |
| 2025-05-12 | 7,832,601 | [10-Q 2025-05-13] |
| 2025-09-16 | 8,155,948 | [10-K 2025-09-17] |
| 2025-11-11 | 9,253,897 | [10-Q 2025-11-12] |
| 2026-02-11 | 10,050,743 | [10-Q 2026-02-12] |
| 2026-05-13 | 10,789,546 | [10-Q 2026-05-14] |
| 2026-09-09 | 12,344,736 | [10-K 2026-09-10] |
- Shelf registration
- S-1 filed 2026-10-06; no effectiveness notice found in EDGAR [S-1 2026-10-06]
Listing status
Current status: 5 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-07-13. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-07-13 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-07-13] |
| 2026-01-22 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-01-22] |
| 2025-07-03 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-07-03] |
| 2025-01-21 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-01-21] |
| 2024-11-27 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2024-11-27] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-20 | Shorrer Doron | grant | 31,569 | — | [4 2026-08-24] |
| 2026-08-20 | Manieu Alexandre Weinstein | grant | 180,000 | — | [4 2026-08-24] |
| 2026-06-30 | Manieu Alexandre Weinstein | grant | 641 | — | [4 2026-07-01] |
| 2026-04-21 | Manieu Alexandre Weinstein | grant | 312,500 | $2.00 | [4 2026-05-04] |
| 2026-03-31 | Manieu Alexandre Weinstein | grant | 312,500 | $2.00 | [4 2026-05-04] |
| 2025-12-08 | Manieu Alexandre Weinstein | grant | 625,000 | $2.00 | [4 2026-01-05] |
| 2025-12-04 | Manieu Alexandre Weinstein | grant | 519 | — | [4 2025-12-08] |
| 2025-12-04 | Ajchenbaum Eitan | grant | 668 | — | [4 2025-12-08] |
| 2025-12-04 | Yanay Yaky | grant | 6,588 | — | [4 2025-12-08] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-06 | S-1 | Registration statement |
| 2026-09-11 | S-3 | Registration statement |
| 2026-09-10 | 10-K | Annual report |
| 2026-08-28 | 424B5 | Prospectus or prospectus supplement |
| 2026-08-28 | 8-K | Material agreement entered; Unregistered sale of equity |
| 2026-08-27 | 424B3 | Prospectus or prospectus supplement |
| 2026-08-17 | 8-K | Other events |
| 2026-07-14 | 8-K | Other events |
| 2026-07-13 | 8-K | Listing notice or transfer |
| 2026-07-01 | 13D/A | Beneficial ownership report (5%+ holder) |
| 2026-06-22 | 8-K | Material agreement entered; Director or officer change; Shareholder vote results |
| 2026-06-01 | 8-K | Other events |
Alerts for $PLUR
Email me when Pluri Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.